Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Correa

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Plos One|August 7, 2019
Intragenic antimicrobial peptides (IAPs) from human proteins with potent antimicrobial and anti-inflammatory activityGuilherme D Brand, Marcelo H S Ramada, Júlia R Manickchand, et al.
International Journal of Cardiology. Heart & Vasculature|June 24, 2024
One-year longitudinal changes of peripheral CD4+ T-lymphocyte counts, gut microbiome, and plaque vulnerability after an acute coronary syndromeAna I Fernández-Avila, Enrique Gutiérrez-Ibanes, Irene Martín de Miguel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 2, 2026
OPERATIONAL TOLERANCE FOLLOWING INTESTINAL TRANSPLANTATION: A CASE REPORT WITH COMPREHENSIVE IMMUNE FOLLOW-UP FROM TRANSPLANT DAY TO THREE YEARS POST-IMMUNOSUPPRESSION WITHDRAWALRodrigo Papa-Gobbi, Rocío González-Sacristán, Elena Sánchez-Zapardiel, et al.
Transplantation|October 22, 2024
Promoting Equitable and Affordable Patient Access to Safe and Effective Innovations in Donation and Transplantation of Substances of Human Origin and Derived TherapiesNatividad Cuende, Stefan G Tullius, Ander Izeta, et al.
International Journal of Molecular Sciences|April 17, 2025
Changes in T Lymphocytes and Cytokines After Anti-TNF Treatment in Pediatric Inflammatory Bowel Disease: Association with Response to Pharmacologic TherapyPaula Zapata-Cobo, Sara Salvador-Martín, Sergio Gil-Manso, et al.
The Journal of Biological Chemistry|February 23, 2023
Release of immunomodulatory peptides at bacterial membrane interfaces as a novel strategy to fight microorganismsThiago Viana de Freitas, Utsa Karmakar, Andreanne G Vasconcelos, et al.
Expert Review of Clinical Pharmacology|January 27, 2021
Clinical course of severe patients with COVID-19 treated with tocilizumab: report from a cohort study in SpainEsther Chamorro-de-Vega, Carmen-Guadalupe Rodriguez-Gonzalez, Silvia Manrique-Rodríguez, et al.
Cell Reports|August 14, 2021
Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individualsDaniel Lozano-Ojalvo, Carmen Camara, Eduardo Lopez-Granados, et al.
Nature Biotechnology|June 13, 2022
Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCRMegan Schwarz, Denis Torre, Daniel Lozano-Ojalvo, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Plos One|August 7, 2019
Intragenic antimicrobial peptides (IAPs) from human proteins with potent antimicrobial and anti-inflammatory activityGuilherme D Brand, Marcelo H S Ramada, Júlia R Manickchand, et al.
International Journal of Cardiology. Heart & Vasculature|June 24, 2024
One-year longitudinal changes of peripheral CD4+ T-lymphocyte counts, gut microbiome, and plaque vulnerability after an acute coronary syndromeAna I Fernández-Avila, Enrique Gutiérrez-Ibanes, Irene Martín de Miguel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 2, 2026
OPERATIONAL TOLERANCE FOLLOWING INTESTINAL TRANSPLANTATION: A CASE REPORT WITH COMPREHENSIVE IMMUNE FOLLOW-UP FROM TRANSPLANT DAY TO THREE YEARS POST-IMMUNOSUPPRESSION WITHDRAWALRodrigo Papa-Gobbi, Rocío González-Sacristán, Elena Sánchez-Zapardiel, et al.
Transplantation|October 22, 2024
Promoting Equitable and Affordable Patient Access to Safe and Effective Innovations in Donation and Transplantation of Substances of Human Origin and Derived TherapiesNatividad Cuende, Stefan G Tullius, Ander Izeta, et al.
International Journal of Molecular Sciences|April 17, 2025
Changes in T Lymphocytes and Cytokines After Anti-TNF Treatment in Pediatric Inflammatory Bowel Disease: Association with Response to Pharmacologic TherapyPaula Zapata-Cobo, Sara Salvador-Martín, Sergio Gil-Manso, et al.
The Journal of Biological Chemistry|February 23, 2023
Release of immunomodulatory peptides at bacterial membrane interfaces as a novel strategy to fight microorganismsThiago Viana de Freitas, Utsa Karmakar, Andreanne G Vasconcelos, et al.
Expert Review of Clinical Pharmacology|January 27, 2021
Clinical course of severe patients with COVID-19 treated with tocilizumab: report from a cohort study in SpainEsther Chamorro-de-Vega, Carmen-Guadalupe Rodriguez-Gonzalez, Silvia Manrique-Rodríguez, et al.
Cell Reports|August 14, 2021
Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individualsDaniel Lozano-Ojalvo, Carmen Camara, Eduardo Lopez-Granados, et al.
Nature Biotechnology|June 13, 2022
Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCRMegan Schwarz, Denis Torre, Daniel Lozano-Ojalvo, et al.
Pageof 9